Multidisciplinary treatment for multiple hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignancies in Japan. However, few HCC patients are candidates for curative surgical resection, due to either associated liver cirrhosis or the presence of multiple tumor nodules in the liver. Several modalities have been used to treat HCC patients including transcatheter arterial embolization (TAE), hepatic arterial infusion, ultrasound (US) guided ethanol injection, radiation, immunotherapy, and hyperthermia, but satisfactory clinical results have not yet been obtained. These non-curative patients can be treated with reduction surgery or hepatic arterial infusion therapy using an implantable injection port (IIP). In this chapter, we will discuss our multidisciplinary treatment of unresectable (non-curative) hepatocellular carcinomas, specially targeting Stage IV-a (IM2,3) multiple HCCs as defined in .
KeywordsTranscatheter Arterial Embolization Hepatic Arterial Infusion Multiple HCCs Bilateral Lobe Superior Pancreaticoduodenal Artery
Unable to display preview. Download preview PDF.
- 1.Liver cancer study group of Japan (1987) The general rules for the clinical and pathological study of primary liver cancer, ( 2nd edn ), Kanehara, TokyoGoogle Scholar
- 3.Takasaki K, Kobayashi S, Tanaka S, Saito A, Yamamoto M, Hanyu F (1990) Highly anatomically systematized hepatic resection with glisonean sheath code transection at the hepatic hilus. Int Surgery 75: 73–77Google Scholar
- 4.Takasaki K, Saito A, Nakagawa M, Muto H, Watayo T, Akimoto S, Tanaka S, Yamamoto M, Yamaguchi M, Shimamura Y, Kobayashi S (1986) Enhanced intra-operative ultrasonography. Advanced diagnostic method to determine the tumor bearing area in the liver by intra-arterial and portal injection of carbon dioxide gas. Proc JSUM pp 1061–1062Google Scholar